Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
CD388 is administered as a single 450-milligram subcutaneous dose in adults and adolescents
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
Clinical trials found that 77% of patients went into remission after receiving obe-cel
Data show adjuvant Verzenio plus endocrine therapy extends overall survival and sustains long-term improvements in invasive disease-free survival
Globally, Abbott has received reports of 736 severe adverse events linked to the issue, including seven deaths (none in the US)
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
The proposed transaction will be effected as a share swap
Subscribe To Our Newsletter & Stay Updated
